KRAS Lung Cancer- Hope & The Future of Treatments with Dr Fawzi Abu Rous | Pt 3/3

he future of KRAS lung cancer treatment is moving fast ..here is what patients need to know about resistance, clinical trials, and emerging therapies, with thoracic oncologist Dr. Fawzi Abu RousIn the final part of the Young Lung Cancer Initiative KRAS Lung Cancer Biomarker Education Series, Dr. Fawzi Abu Rous of Henry Ford Cancer Institute walks us through the KRAS pipeline beyond G12C, how resistance develops on targeted therapy, and how patients can find clinical trials and stay informed over time.If you or a loved one is living with KRASnon-small cell lung cancer (NSCLC), this conversation is packed with practical next steps and a big dose of hope. KRAS is no longer undruggable.This episode is proudly sponsored by Revolution Medicines.About Young Lung Cancer Initiative (YLCI) The YLCI is a 501(c)(3) nonprofit dedicated to the young-onset community. We provide support, research, and advocacy to ensure that no young person faces a lung cancer diagnosis alone.Disclaimer: This podcast is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.